Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cabazitaxel
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 18
Trial IDs: TED12689, NCI-2014-00195, U1111-1128-5704, NCT01751308
Cabazitaxel with or without Abiraterone Acetate and Prednisone in Treating Patients with Stage IV, Hormone Resistant Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18 to 95
Trial IDs: 13-1489, NCI-2013-01356, NCT01845792
Abiraterone Acetate with or without Cabazitaxel in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-046, NCI-2014-01894, c12-108, NCT02218606
Cabazitaxel, Intensity-Modulated Radiation Therapy, and Hormone Therapy in Treating Patients with Locally Advanced High-Risk Prostate Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11D.243, NCI-2011-02420, 2011-32, NCT01420250
Tasquinimod and Cabazitaxel in Treating Patients with Metastatic Hormone Resistant Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 79
Trial IDs: Pro00032421, NCI-2013-01900, c11-082, NCT01513733
Start Over